105 related articles for article (PubMed ID: 34438249)
1. Delta-5-desaturase: A novel therapeutic target for cancer management.
Pang L; Shah H; Xu Y; Qian S
Transl Oncol; 2021 Nov; 14(11):101207. PubMed ID: 34438249
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of delta-5-desaturase promotes the anti-cancer activity of dihomo-γ-linolenic acid and enhances the efficacy of chemotherapy in colon cancer cells expressing COX-2.
Xu Y; Yang X; Zhao P; Yang Z; Yan C; Guo B; Qian SY
Free Radic Biol Med; 2016 Jul; 96():67-77. PubMed ID: 27101738
[TBL] [Abstract][Full Text] [Related]
3. Knockdown delta-5-desaturase promotes the formation of a novel free radical byproduct from COX-catalyzed ω-6 peroxidation to induce apoptosis and sensitize pancreatic cancer cells to chemotherapy drugs.
Yang X; Xu Y; Brooks A; Guo B; Miskimins KW; Qian SY
Free Radic Biol Med; 2016 Aug; 97():342-350. PubMed ID: 27368132
[TBL] [Abstract][Full Text] [Related]
4. Knockdown delta-5-desaturase in breast cancer cells that overexpress COX-2 results in inhibition of growth, migration and invasion via a dihomo-γ-linolenic acid peroxidation dependent mechanism.
Xu Y; Yang X; Wang T; Yang L; He YY; Miskimins K; Qian SY
BMC Cancer; 2018 Mar; 18(1):330. PubMed ID: 29587668
[TBL] [Abstract][Full Text] [Related]
5. Dihomo-γ-linolenic acid inhibits growth of xenograft tumors in mice bearing human pancreatic cancer cells (BxPC-3) transfected with delta-5-desaturase shRNA.
Yang X; Xu Y; Gao D; Yang L; Qian SY
Redox Biol; 2019 Jan; 20():236-246. PubMed ID: 30384258
[TBL] [Abstract][Full Text] [Related]
6. EpCAM-Targeted 3WJ RNA Nanoparticle Harboring Delta-5-Desaturase siRNA Inhibited Lung Tumor Formation via DGLA Peroxidation.
Pang L; Shah H; Wang H; Shu D; Qian SY; Sathish V
Mol Ther Nucleic Acids; 2020 Dec; 22():222-235. PubMed ID: 33230429
[TBL] [Abstract][Full Text] [Related]
7. Free radical derivatives formed from cyclooxygenase-catalyzed dihomo-γ-linolenic acid peroxidation can attenuate colon cancer cell growth and enhance 5-fluorouracil's cytotoxicity.
Xu Y; Qi J; Yang X; Wu E; Qian SY
Redox Biol; 2014; 2():610-8. PubMed ID: 25114837
[TBL] [Abstract][Full Text] [Related]
8. A Novel Orally Available Delta-5 Desaturase Inhibitor Prevents Atherosclerotic Lesions Accompanied by Changes in Fatty Acid Composition and Eicosanoid Production in
Takagahara S; Shinohara H; Itokawa S; Satomi Y; Ando A; Yamamoto T; Suzuki H; Fujimoto T; Kubo K; Ikeda S
J Pharmacol Exp Ther; 2019 Nov; 371(2):290-298. PubMed ID: 31488602
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibitory and anti-metastatic activity of epithelial cell adhesion molecule targeted three-way junctional delta-5-desaturase siRNA nanoparticle for breast cancer therapy.
Shah H; Pang L; Wang H; Shu D; Qian SY; Sathish V
Nanomedicine; 2020 Nov; 30():102298. PubMed ID: 32931930
[TBL] [Abstract][Full Text] [Related]
10. Dihomo-γ-linolenic acid inhibits xenograft tumor growth in mice bearing shRNA-transfected HCA-7 cells targeting delta-5-desaturase.
Xu Y; Yang X; Gao D; Yang L; Miskimins K; Qian SY
BMC Cancer; 2018 Dec; 18(1):1268. PubMed ID: 30567534
[TBL] [Abstract][Full Text] [Related]
11. Specific delivery of delta-5-desaturase siRNA via RNA nanoparticles supplemented with dihomo-γ-linolenic acid for colon cancer suppression.
Xu Y; Pang L; Wang H; Xu C; Shah H; Guo P; Shu D; Qian SY
Redox Biol; 2019 Feb; 21():101085. PubMed ID: 30584980
[TBL] [Abstract][Full Text] [Related]
12. Iminodibenzyl redirected cyclooxygenase-2 catalyzed dihomo-γ-linolenic acid peroxidation pattern in lung cancer.
Pang L; Shah H; Qian S; Sathish V
Free Radic Biol Med; 2021 Aug; 172():167-180. PubMed ID: 34102280
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of serum dihomo-γ-linolenic acid level and estimated Δ-5 desaturase activity in patients with hepatic steatosis.
Matsuda M; Kawamoto T; Tamura R
Obes Res Clin Pract; 2017; 11(1):34-43. PubMed ID: 26964726
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells.
Yang X; Xu Y; Wang T; Shu D; Guo P; Miskimins K; Qian SY
Redox Biol; 2017 Apr; 11():653-662. PubMed ID: 28157665
[TBL] [Abstract][Full Text] [Related]
15. A common variant in ARHGEF10 alters delta-6 desaturase activity and influence susceptibility to hypertriglyceridemia.
de Toro-Martín J; Guénard F; Rudkowska I; Lemieux S; Couture P; Vohl MC
J Clin Lipidol; 2018; 12(2):311-320.e3. PubMed ID: 29246731
[TBL] [Abstract][Full Text] [Related]
16. Iminodibenzyl induced redirected COX-2 activity inhibits breast cancer progression.
Shah H; Pang L; Qian S; Sathish V
NPJ Breast Cancer; 2021 Sep; 7(1):122. PubMed ID: 34535685
[TBL] [Abstract][Full Text] [Related]
17. T-3364366 Targets the Desaturase Domain of Delta-5 Desaturase with Nanomolar Potency and a Multihour Residence Time.
Miyahisa I; Suzuki H; Mizukami A; Tanaka Y; Ono M; Hixon MS; Matsui J
ACS Med Chem Lett; 2016 Sep; 7(9):868-72. PubMed ID: 27660693
[TBL] [Abstract][Full Text] [Related]
18. Estimated Elovl6 and delta-5 desaturase activities might represent potential markers for insulin resistance in Japanese adults.
Moriyama K; Masuda Y; Suzuki N; Yamada C; Kishimoto N; Takashimizu S; Kubo A; Nishizaki Y
J Diabetes Metab Disord; 2022 Jun; 21(1):197-207. PubMed ID: 35673485
[TBL] [Abstract][Full Text] [Related]
19. A Novel Selective Inhibitor of Delta-5 Desaturase Lowers Insulin Resistance and Reduces Body Weight in Diet-Induced Obese C57BL/6J Mice.
Yashiro H; Takagahara S; Tamura YO; Miyahisa I; Matsui J; Suzuki H; Ikeda S; Watanabe M
PLoS One; 2016; 11(11):e0166198. PubMed ID: 27832159
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in FADS1 and ELOVL2 increase level of arachidonic acid and the risk of Alzheimer's disease in the Tunisian population.
Hammouda S; Ghzaiel I; Khamlaoui W; Hammami S; Mhenni SY; Samet S; Hammami M; Zarrouk A
Prostaglandins Leukot Essent Fatty Acids; 2020 Sep; 160():102159. PubMed ID: 32682282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
